Identification of Myocardial Disarray in Patients With Hypertrophic Cardiomyopathy and Ventricular Arrhythmias
暂无分享,去创建一个
Matthew D. Robson | Stefan K. Piechnik | Stefan Neubauer | Rina Ariga | Jane M. Francis | Sanjay G. Manohar | Elizabeth M. Tunnicliffe | M. Robson | J. Francis | S. Piechnik | S. Neubauer | S. Manohar | H. Watkins | R. Ariga | E. Tunnicliffe | Betty Raman | Masliza Mahmod | Hugh Watkins | M. Mahmod | B. Raman
[1] Jonathan D. Suever,et al. Evaluation of the impact of strain correction on the orientation of cardiac diffusion tensors with in vivo and ex vivo porcine hearts , 2018, Magnetic resonance in medicine.
[2] Marcel P. Jackowski,et al. Myocardial Scar Delineation Using Diffusion Tensor Magnetic Resonance Tractography , 2018, Journal of the American Heart Association.
[3] Himanshu Bhat,et al. Diffusion Tractography of the Entire Left Ventricle by Using Free-breathing Accelerated Simultaneous Multisection Imaging. , 2017, Radiology.
[4] Eric Aliotta,et al. Assessment of Myocardial Microstructural Dynamics by In Vivo Diffusion Tensor Cardiac Magnetic Resonance , 2017, Journal of the American College of Cardiology.
[5] Holden H. Wu,et al. Convex optimized diffusion encoding (CODE) gradient waveforms for minimum echo time and bulk motion–compensated diffusion‐weighted MRI , 2017, Magnetic resonance in medicine.
[6] David Atkinson,et al. Second‐order motion‐compensated spin echo diffusion tensor imaging of the human heart , 2016, Magnetic resonance in medicine.
[7] B. Maron,et al. Independent Assessment of the European Society of Cardiology Sudden Death Risk Model for Hypertrophic Cardiomyopathy. , 2015, The American journal of cardiology.
[8] N. Geller,et al. Hypertrophic Cardiomyopathy Registry: The rationale and design of an international, observational study of hypertrophic cardiomyopathy. , 2015, American heart journal.
[9] C. Autore,et al. Clinical Impact of Nonsustained Ventricular Tachycardia Recorded by the Implantable Cardioverter‐Defibrillator in Patients with Hypertrophic Cardiomyopathy , 2014, Journal of cardiovascular electrophysiology.
[10] Frank B Sachse,et al. Characterization of diffuse fibrosis in the failing human heart via diffusion tensor imaging and quantitative histological validation , 2014, NMR in biomedicine.
[11] David Atkinson,et al. Dual-Phase Cardiac Diffusion Tensor Imaging with Strain Correction , 2014, PLoS ONE.
[12] Stefan Neubauer,et al. Intercentre reproducibility of cardiac apparent diffusion coefficient and fractional anisotropy in healthy volunteers , 2014, Journal of Cardiovascular Magnetic Resonance.
[13] M. Robson,et al. T1 mapping for myocardial extracellular volume measurement by CMR: bolus only versus primed infusion technique. , 2013, JACC. Cardiovascular imaging.
[14] P. Lambiase,et al. A validation study of the 2003 American College of Cardiology/European Society of Cardiology and 2011 American College of Cardiology Foundation/American Heart Association risk stratification and treatment algorithms for sudden cardiac death in patients with hypertrophic cardiomyopathy , 2013, Heart.
[15] D. Pennell,et al. Reproducibility of in-vivo diffusion tensor cardiovascular magnetic resonance in hypertrophic cardiomyopathy , 2012, Journal of Cardiovascular Magnetic Resonance.
[16] C. Autore,et al. High risk for sudden death identified by electrocardiographic loop recording in a patient with hypertrophic cardiomyopathy without major risk factors. , 2011, The American journal of cardiology.
[17] I. Kowalik,et al. Implantable Cardioverter‐Defibrillator in Patients With Hypertrophic Cardiomyopathy: Efficacy and Complications of the Therapy in Long‐Term Follow‐up , 2010, Journal of cardiovascular electrophysiology.
[18] M. Sheppard,et al. Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy using cardiovascular magnetic resonance , 2010 .
[19] Timothy G Reese,et al. Imaging myocardial fiber disarray and intramural strain hypokinesis in hypertrophic cardiomyopathy with MRI , 2006, Journal of magnetic resonance imaging : JMRI.
[20] Dudley J Pennell,et al. The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. , 2004, Journal of the American College of Cardiology.
[21] P. Elliott,et al. Hypertrophic cardiomyopathy , 2004, The Lancet.
[22] Timothy G Reese,et al. Diffusion tensor MRI of myocardial fibers and sheets: Correspondence with visible cut‐face texture , 2003, Journal of magnetic resonance imaging : JMRI.
[23] P. Elliott,et al. Hypertrophic Cardiomyopathy: Histopathological Features of Sudden Death in Cardiac Troponin T Disease , 2001, Circulation.
[24] W J McKenna,et al. Relation between myocyte disarray and outcome in hypertrophic cardiomyopathy. , 2001, The American journal of cardiology.
[25] B. Maron,et al. Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large non-referral-based patient population. , 2000, Circulation.
[26] R L Winslow,et al. Direct histological validation of diffusion tensor MRI in formaldehyde‐fixed myocardium , 2000, Magnetic resonance in medicine.
[27] M. Link,et al. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. , 2000, The New England journal of medicine.
[28] W. Roberts,et al. Morphology and significance of the left ventricular collagen network in young patients with hypertrophic cardiomyopathy and sudden cardiac death. , 2000, Journal of the American College of Cardiology.
[29] John Forder,et al. Histological validation of myocardial microstructure obtained from diffusion tensor magnetic resonance imaging. , 1998, American journal of physiology. Heart and circulatory physiology.
[30] C. Henriquez,et al. Magnetic resonance myocardial fiber-orientation mapping with direct histological correlation. , 1998, American journal of physiology. Heart and circulatory physiology.
[31] C. Henriquez,et al. Magnetic resonance myocardial fiber-orientation mapping with direct histological correlation. , 1998, The American journal of physiology.
[32] B. Maron,et al. Hypertrophic cardiomyopathy in Tuscany: clinical course and outcome in an unselected regional population. , 1995, Journal of the American College of Cardiology.
[33] R. Saumarez,et al. Electrophysiological investigation of patients with hypertrophic cardiomyopathy. Evidence that slowed intraventricular conduction is associated with an increased risk of sudden death. , 1994, British heart journal.
[34] C. Autore,et al. Prognosis of Asymptomatic Patients With Hypertrophic Cardiomyopathy and Nonsustained Ventricular Tachycardia , 1994, Circulation.
[35] W. Roberts,et al. Myocardial disarray at junction of ventricular septum and left and right ventricular free walls in hypertrophic cardiomyopathy. , 1992, The American journal of cardiology.
[36] M. Silver,et al. An improved method for detecting and quantifying cardiac muscle disarray in hypertrophic cardiomyopathy. , 1989, American heart journal.
[37] W. Roberts,et al. Regional myocyte hypertrophy and increased interstitial myocardial fibrosis in hypertrophic cardiomyopathy. , 1987, The American journal of cardiology.
[38] B. Maron,et al. Prognostic significance of 24 hour ambulatory electrocardiographic monitoring in patients with hypertrophic cardiomyopathy: a prospective study. , 1981, The American journal of cardiology.
[39] W. Mckenna,et al. Arrhythmia in hypertrophic cardiomyopathy. I: Influence on prognosis. , 1981, British heart journal.
[40] A E Becker,et al. Left ventricular fibre architecture in man. , 1981, British heart journal.
[41] J. Ross,et al. Fiber Orientation in the Canine Left Ventricle during Diastole and Systole , 1969, Circulation research.